Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simenepag isopropyl (AGN-210669) vs Bimatoprost in Glaucoma/OHT
NCT01001195Phase 2Completed
- Sponsor
- Allergan
- Start
- Nov 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of simenepag isopropyl in Open-angle glaucoma (OAG) and ocular hypertension (4 arms), sponsored by Allergan. Primary endpoint: Change From Baseline in Average Eye Intraocular Pressure at Day 29. Started Nov 2009; status: completed.
02
Drugs
simenepag isopropyl
03
Conditions
Open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT01001195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01001195.